ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine
(group practice)

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,987Medicare Part D Prescriptions Filled, Including Refills

Rank: 314 out of 2888

$591K Total Retail Price of All Prescriptions

Rank: 640 out of 2888

589 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

12% of this provider’s 589 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 11,642 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$46 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
METOPROLOL TARTRATE 1,076 955 1 10
CLOPIDOGREL 721 639 2 30
PLAVIX 503 459 3 40
METOPROLOL SUCCINATE 477 443 4 11
LOSARTAN POTASSIUM 443 417 5 18
SIMVASTATIN 412 365 6 2
FUROSEMIDE 410 366 7 6
PRAVASTATIN SODIUM 392 368 8 12
NIFEDIPINE ER 372 364 9 76
HYDROCODONE-ACETAMINOPHEN 358 298 S3 10 4
ISOSORBIDE MONONITRATE ER 349 308 11 51
LEVOTHYROXINE SODIUM 344 322 12 1
POTASSIUM CHLORIDE 312 271 13 14
LISINOPRIL 302 268 14 3
WARFARIN SODIUM 291 261 15 22
AMLODIPINE BESYLATE 216 204 16 5
METFORMIN HCL 212 197 17 8
ATORVASTATIN CALCIUM 190 169 18 9
DIOVAN 177 165 19 35
PROPAFENONE HCL 169 159 20 409
OMEPRAZOLE 167 162 21 7
CARVEDILOL 157 117 22 21
ALLOPURINOL 156 144 23 37
SPIRONOLACTONE 143 120 24 70
DIGOXIN 135 126 25 55
PANTOPRAZOLE SODIUM 125 93 26 33
NITROSTAT 125 114 26 240
AMIODARONE HCL 114 114 28 167
LOVASTATIN 103 93 29 41
HYDRALAZINE HCL 103 102 29 59
ATENOLOL 102 100 31 25
RANITIDINE HCL 101 100 32 56
CRESTOR 90 61 33 20
TICLOPIDINE HCL 89 88 R 10 34 496
CLONIDINE HCL 81 77 35 39
CIPROFLOXACIN HCL 76 59 36 47
LOSARTAN-HYDROCHLOROTHIAZIDE 76 69 36 46
TAMSULOSIN HCL 73 73 38 29
CYCLOBENZAPRINE HCL 70 61 R 39 68
ZOLPIDEM TARTRATE 69 65 40 17
KLOR-CON 10 65 54 41 195
SERTRALINE HCL 64 58 42 27
TRAMADOL HCL 64 53 42 16
RAMIPRIL 61 49 44 73
GEMFIBROZIL 57 51 45 98
NEXIUM 56 51 46 19
FLECAINIDE ACETATE 56 56 46 407
NIFEDICAL XL 55 54 48 190
GLIPIZIDE 54 42 49 50
GABAPENTIN 52 46 50 13
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 3, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.